Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
11 Mar, 26
New guidelines on pulmonary embolism (PE) offer evidence based recommendations for evaluating, managing, and following up adults with acute PE. Endorsed by eight societies, it stresses multidisciplinary care across emergency, inpatient, & outpatient settings.
26 Feb, 26
ADA 2026 outlines the standards for obesity pharmacotherapy. It recommends combining person-centered medication with lifestyle changes for adults with obesity. It details weight-loss targets and drug benefits for comorbidities
16 Mar, 26
Lancet Infect Dis.
- Meta analysis showed that typhoid caused substantial morbidity; delirium/confusion occurred commonly (26.5%)
- Typhoid case fatality ratio (CFR) was 2.1% & typhoid intestinal perforation CFR was 16.3%; highest in Africa (4.7%), followed by America (2.9%) and Asia (1.2%)
- Higher typhoid CFR was seen in facility-based vs. community-based recruitment sites (2.3% vs. 0.9%) & among those aged <15y (2.7%)
16 Mar, 26Endocrinol Diabetes ...
- A systematic review & meta-analysis of 23 RCTs compared SGLT 2i+metformin vs. other metformin containing oral dual therapies in T2DM
- HbA1c reduction was comparable at 24/52 weeks, at 52 weeks, patients on SGLT 2i+metformin had lower hypoglycemia risk (RR 0.27) & greater body weight reduction (MD –2.59 kg), but increased genital infection risk (RR 5.08)
- Other safety outcomes were comparable.
13 Mar, 26RMD Open
- Exercise gives small, short term pain relief in knee osteoarthritis (OA) (−10.8 to −12.4) with very low certainty
- Hip OA shows negligible benefit (−6.7), and hand OA small effects (−10.0)
- Pain and function outcomes were similar to those achieved with education intervention, analgesics, injections and manual therapy.
12 Mar, 26Diabetes Obes Metab.
- In a US case–control study (39,281 T2DM cases, 58,751 controls), predictors of progression from prediabetes to T2DM included age 35–64 (OR 1.33–1.49 vs. 18–34), obesity (OR 1.45), CVD (OR 1.64), OSA (OR 1.36), MASH (OR 1.37), & neuropathy (OR 1.19)
- American-Africans (OR 1.27) & Hispanic (OR 1.21) patients had higher odds vs. White (p<0.0001)
- These comorbidities highlight key risk factors for T2DM progression.
2 Mar, 26
Featured
6 Mar, 26
4 Mar, 26
25 Feb, 26
